If you are not happy with the results below please do another search
Johnson & Johnson has entered into a definitive agreement to acquire Ambrx Biopharma, a clinical-stage biopharmaceutical company with a proprietary synthetic biology technology platform to design and develop next-generation antibody drug conjugates (ADCs), in an all-cash merger transaction for a total equity value of approximately $2 billion, or $1.9 billion net of estimated cash acquired.
Getting the most from every drop – new advances in blood separation Alexandra Sommer, Senior Product Manager, Clinical Diagnostics at Tecan
OGT, a leading global provider of genomic research and diagnostic solutions, proudly announces the opening of state-of-the-art facilities within the Oxford Technology Park. The move represents a multi-million-pound investment, fuelled by consistent company growth and growing customer demand.
In less time than it will take you to read this article, an artificial intelligence-driven system was able to autonomously learn about certain Nobel Prize-winning chemical reactions and design a successful laboratory procedure to make them. The AI did all that in just a few minutes – and nailed it on the first try.
Leading computational biology company PrecisionLife, which is driving precision medicine in complex chronic diseases, the ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh, have been awarded a £622,000 (about US$794,000) grant by Innovate UK’s Advancing Precision Medicine programme […]
Antabio SAS, a clinical stage biopharmaceutical company developing novel treatments for severe drug-resistant bacterial infections, has raised €25 million in a Series B financing round, which will enable the company to complete the phase 2 clinical studies of MEM-ANT3310, a next generation antibacterial.
Metrion Biosciences, a specialist ion channel CRO and drug discovery company, has secured £3.5 million (about US$3,19 million) in new equity financing, including £2.5m from lead investor Maven Capital Partners and £1 million from existing investor, Gresham House Ventures. The funding will be used to further expand Metrion’s laboratories in Cambridge, UK, invest in specialist […]
Aptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, has entered into a material agreement with a biotechnology company developing genetic medicines.
ProBioGen’s Transposase binds to specific epigenetic histone marks characteristic for highly active genome regions. Omitting the plasmid backbone, multiple transposable elements carrying the transgene cassette are specifically inserted resulting in highly stable and high expressing clones.
On 1 December 2023, Ana-Maria Šimundić took up the newly created position as director of Global Medical & Clinical Affairs at Greiner Bio-One. In this role, she will represent Greiner Bio-One in national and international professional circles as well as foster exchange with experts in science and the field. Her area of responsibility includes all […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
